RecruitingNot ApplicableNCT06059586

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy


Sponsor

Indiana University

Enrollment

20 participants

Start Date

Jan 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the feasibility of adding pre-rehabilitation pelvic health physical therapy to standard of care radiation therapy treatment plan for female patients who have been diagnosed with cervical, vaginal, vulvar, uterine, or anal cancer and are a candidate for curative pelvic radiation with external beam. Participants will receive education on using a vaginal dilator for use during treatment and complete questionnaires looking at pain and sexual function.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Dilator feasability and a behavioral approach called Pelvic health therapy for people with dyspareunia, pelvic pain, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPelvic health therapy

Female Sexual Function Index (FSFI) and VAS Pain Scale Questionnaires, Physical Therapy Evaluation including Pelvic Floor Muscle Examination, Dilator Education

DEVICEDilator feasability

Patient Adherence to Vaginal Dilation Questionnaire


Locations(3)

IU Health West

Avon, Indiana, United States

IU Health Schwarz Cancer Center

Carmel, Indiana, United States

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06059586


Related Trials